Sort by
Refine Your Search
-
the intersection of computer science and drug research, to support strategic focus on the use of AI in scientific research within the general area related to drug security. The position is at
-
mechanisms of normal hematopoietic and leukemic cells and apply computational biology models to address specific questions in orthogonal multiomics approaches to analyses of signaling pathways in disease and
-
fusion proteins. We aim to understand the mechanisms by which oncogenic fusion proteins drive leukemia, in order to disrupt their activity for therapeutic purposes. Oncogenic fusion proteins can promote
-
are available from 1 July 2025 to 30 June 2026 in the first instance. Based in the interdisciplinary Living Systems Institute, the successful applicants will join a world-leading programme of investigations